Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression, Rheumatology, vol.4, issue.4, pp.607-619, 2009. ,
DOI : 10.1038/ncprheum0760
Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis, Arthritis & Rheumatism, vol.40, issue.5, pp.1571-1577, 2005. ,
DOI : 10.7326/0003-4819-122-9-199505010-00010
Response of Mucocutaneous Lesions to Rituximab in a Case of Melanoma Differentiation Antigen 5-Related Dermatomyositis, Dermatology, vol.225, issue.4, pp.376-80, 2012. ,
DOI : 10.1159/000346573
Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy, Journal of the European Academy of Dermatology and Venereology, vol.38, issue.8, pp.1097-1102, 2014. ,
DOI : 10.3899/jrheum.101220
Meta-analysis of the association of dermatomyositis and polymyositis with cancer, British Journal of Dermatology, vol.40, issue.4, pp.838-885, 2013. ,
DOI : 10.1016/j.lpm.2010.12.013
Cutaneous necrosis is predictive of cancer in adult dermatomyositis, Ann Dermatol Venereol, vol.130, pp.313-319, 2003. ,
Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis, Journal of Immunology Research, vol.71, issue.8, p.290797, 2014. ,
DOI : 10.1093/rheumatology/ker408
Dermatomyosite et pneumopathie interstitielle rapidement ??volutive associ??es aux auto-anticorps anti-MDA-5??: une pr??sentation clinique atypique, Annales de Dermatologie et de V??n??r??ologie, vol.140, issue.10, pp.628-662, 2013. ,
DOI : 10.1016/j.annder.2013.04.083
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A??retrospective study, Journal of the American Academy of Dermatology, vol.65, issue.1, pp.25-34, 2011. ,
DOI : 10.1016/j.jaad.2010.09.016
Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody, Arthritis Care & Research, vol.49, issue.10, pp.1602-1612, 2012. ,
DOI : 10.1093/rheumatology/keq153
Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis, Arthritis Care & Research, vol.64, issue.8, pp.1316-1340, 2013. ,
DOI : 10.1002/art.34657
Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease, The Journal of Dermatology, vol.41, issue.7, pp.664-669, 2014. ,
DOI : 10.1111/1346-8138.12524
Pneumopathie infiltrante diffuse associ??e ?? une dermatomyosite amyopathique avec auto-anticorps anti-MDA5, Revue des Maladies Respiratoires, vol.31, issue.9, pp.849-53, 2014. ,
DOI : 10.1016/j.rmr.2014.02.010
Interstitial lung diseases associated with amyopathic dermatomyositis, European Respiratory Journal, vol.28, issue.5, pp.1005-1017, 2006. ,
DOI : 10.1183/09031936.06.00038806
Early Pulmonary Involvement of Anti-CADM-140 Autoantibody-positive Rapidly Progressive Interstitial Lung Disease Preceding Typical Cutaneous Symptoms, Internal Medicine, vol.53, issue.21, pp.2515-2524, 2014. ,
DOI : 10.2169/internalmedicine.53.2769
Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients, Rheumatology International, vol.35, issue.5, pp.1295-302, 2013. ,
DOI : 10.1093/rheumatology/keq073
Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis, Chest, vol.136, issue.5, pp.1341-1348, 2009. ,
DOI : 10.1378/chest.08-2740
Intractable Skin Necrosis and Interstitial Pneumonia in Amyopathic Dermatomyositis, Successfully Treated with Cyclosporin A, Internal Medicine, vol.42, issue.12, pp.1253-1261, 2003. ,
DOI : 10.2169/internalmedicine.42.1253